Suppr超能文献

Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials.

作者信息

Schiller John T, Lowy Douglas R

机构信息

Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

出版信息

J Infect Dis. 2009 Jul 15;200(2):166-71. doi: 10.1086/599988.

Abstract
摘要

相似文献

1
Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials.
J Infect Dis. 2009 Jul 15;200(2):166-71. doi: 10.1086/599988.
5
Human papillomavirus vaccines--immune responses.
Vaccine. 2012 Nov 20;30 Suppl 5:F83-7. doi: 10.1016/j.vaccine.2012.04.106.
8
Developments in L2-based human papillomavirus (HPV) vaccines.
Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23.
9
Two-dose schedule for human papillomavirus vaccine.
Lancet Oncol. 2017 Jan;18(1):e3. doi: 10.1016/S1470-2045(16)30628-3. Epub 2016 Dec 2.
10
Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.
Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. doi: 10.1016/j.vaccine.2006.05.110. Epub 2006 Jun 23.

引用本文的文献

1
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage.
NPJ Vaccines. 2025 May 27;10(1):107. doi: 10.1038/s41541-025-01163-4.
3
The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays.
PLoS Pathog. 2023 Jun 29;19(6):e1011403. doi: 10.1371/journal.ppat.1011403. eCollection 2023 Jun.
4
Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV.
Vaccines (Basel). 2023 Jun 5;11(6):1067. doi: 10.3390/vaccines11061067.
5
Assay Harmonization Study To Measure Immune Response to SARS-CoV-2 Infection and Vaccines: a Serology Methods Study.
Microbiol Spectr. 2023 Jun 15;11(3):e0535322. doi: 10.1128/spectrum.05353-22. Epub 2023 May 16.
7
Multiplex immunoassay to measure antibody response to nine HPV vaccine types.
J Immunol Methods. 2021 Nov;498:113136. doi: 10.1016/j.jim.2021.113136. Epub 2021 Aug 28.
9
Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants.
Pathogens. 2020 Nov 28;9(12):996. doi: 10.3390/pathogens9120996.
10
Immunogenicity of an -produced bivalent human papillomavirus vaccine under different vaccination intervals.
Hum Vaccin Immunother. 2020 Jul 2;16(7):1630-1635. doi: 10.1080/21645515.2020.1761202. Epub 2020 Jun 16.

本文引用的文献

2
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
Vaccine. 2008 Dec 9;26(52):6844-51. doi: 10.1016/j.vaccine.2008.09.073. Epub 2008 Oct 16.
3
An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.
Vaccine. 2008 Aug 19;26 Suppl 10(Suppl 10):K53-61. doi: 10.1016/j.vaccine.2008.06.002.
4
Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.
Vaccine. 2008 Jul 4;26(29-30):3608-16. doi: 10.1016/j.vaccine.2008.04.074. Epub 2008 May 19.
5
Immunobiology of HPV and HPV vaccines.
Gynecol Oncol. 2008 May;109(2 Suppl):S15-21. doi: 10.1016/j.ygyno.2008.02.003.
8
Quadrivalent human papillomavirus vaccine.
Clin Infect Dis. 2007 Sep 1;45(5):609-7. doi: 10.1086/520654. Epub 2007 Jul 25.
9
Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions.
Hum Vaccin. 2007 Jul-Aug;3(4):109-15. doi: 10.4161/hv.3.4.4058. Epub 2007 Feb 24.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验